The Use of a Platform Wound Device for Reducing Infection

Status Completed

Clinical Trial Summary

This study will evaluate the safety and efficacy of a novel Platform Wound Device (PWD) in its delivery of a local antibiotic, 0.1% Gentamycin cream, to prevent or treat infection in torso and extremity wounds. The hypothesis is that the PWD will be a safe and effective method to provide topical antibiotics to a torso or extremity wound, non-inferior to the current standard of care. This treatment will reduce or rapidly eradicate infection.

Clinical Trial Description

This is a prospective, randomized, controlled clinical trial comparing the use of a platform wound device as compared to standard of care to prevent or eliminate infection in torso and extremity wounds. Patients 18-85 years of age admitted for treatment of open wound(s) will be screened for inclusion criteria and asked to consent to participate in the randomized study. The first 10 patients will be treated with the PWD + gentamicin and will serve as a safety subset. Baseline measurement of serum antibiotic concentraion will be taken prior to PWD placement and one day after. Following the safety subset, 50 patients will be randomized to standard of care or to a single application of the PWD + gentamicin. Baseline assessments will be completed on day 0, including screening, pre-procedure wound evaluation, imaging, assessments, and specimen collection. Follow-up assessments will be completed and data gathered at days 1,2,3 and 4. All data collected of the study participants will be used to evaluate the PWD delivery of antibiotic. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04753723
Study type	Interventional
Source	The Metis Foundation
Contact
Status	Completed
Phase	Phase 4
Start date	February 8, 2021
Completion date	May 25, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03948360` - Safety Study of a Novel Wearable Phototherapy System for the Management of Acute Burn Wounds	N/A
Completed	`NCT04277182` - Effect of Propolis Application on Burn Healing	N/A
Enrolling by invitation	`NCT00978705` - Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood	Phase 3
Withdrawn	`NCT03675568` - Non-cultured Autologous Keratinocyte Suspension Versus Traditional Split Skin Graft for Burn Wounds Treatment	N/A
Active, not recruiting	`NCT04828304` - PLASOMA Ultimate Safety & Efficacy Study	N/A
Not yet recruiting	`NCT05649332` - Study to Evaluate the Performance and Safety of the Medical Device Argogen	N/A
Recruiting	`NCT05593523` - Fluorescence-based Detection of Inflammation and Necrosis to Inform Surgical Decision-making and Enhance Outcomes
Completed	`NCT06280053` - HealiAid in the Treatment of Different Wounds	N/A
Enrolling by invitation	`NCT06103409` - MSCs for the Treatment of Burn Wounds	Phase 1/Phase 2
Recruiting	`NCT05796492` - Ultrasound Treatment on Wound Healing Time	N/A
Enrolling by invitation	`NCT04725071` - Immunonutrition Supplementation for Improved Burn Wound Healing in Older Adults	N/A
Suspended	`NCT02577120` - Wound Healing Endpoint and Recurrence	Phase 4
Active, not recruiting	`NCT05341427` - DEVELOPMENT OF A CLINICAL PREDICTION RULES TO IDENTIFY EFFICACY OF PULSED ELECTROMAGNETIC THERAPY ON BURN WOUND HEALING	N/A
Terminated	`NCT03723590` - A Clinical Evaluation of an Esterified Hyaluronic Acid Matrix in Burn Patients for STSG	N/A
Not yet recruiting	`NCT04011306` - A Feasibility Study of a Novel Phototherapy System for the Management of Acute Burns	N/A
Recruiting	`NCT05404191` - Prediction Rules for Low Level Laser on Burn Wounds	N/A
Completed	`NCT02982096` - Study Comparing Healing With Epidermal Fractional Blistergrafting (CellutomeTM) to Acellular Technique	N/A